Showing 201-210 of 333 grants
Title | Institution | Researcher | Program | Duration | Total Award Amount |
---|---|---|---|---|---|
Validation of a Tolerogenic Nanotherapy for Islet Transplantation in a Non-Human Primate Model | Northwestern University | Jacqueline Burke | Cures | 01-July-2023 to 30-June-2026 | $998.275,64 |
Defining the Antigenic Landscape of Islet-Infiltrating T cells in Type 1 Diabetes | University of Pittsburgh | Alok Joglekar | Cures | 01-March-2023 to 28-February-2026 | $900.000,00 |
MRI of Pancreas Perfusion in Response to Glucose | University of Texas at Austin | Jack Virostko | Cures | 01-July-2023 to 30-June-2025 | $187.620,00 |
Exploiting CRISPR Strategy to Modify T-Cell Lipid Signaling and Mitigate T1D Development | The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham | Sasanka Ramanadham | Cures | 01-May-2023 to 30-April-2025 | $199.989,05 |
Cellular Sentinels of Islet Transplant Rejection | California Institute of Technology | Mikhail Shapiro | Cures | 01-July-2023 to 30-June-2026 | $750.000,00 |
Multiplex in vivo imaging of the dynamics of immune-mediated rejection of allogenic islet grafts | The Regents of the University of California, Los Angeles | Oluwatayo Ikotun | Cures | 01-February-2024 to 31-January-2027 | $749.996,25 |
Targeting Prostaglandin F-series Lipids to Counter Beta-Cell-Death and T1D Development | The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham | Sasanka Ramanadham | Cures | 01-May-2023 to 30-April-2026 | $749.763,00 |
IL-37-EXPRESSING TREG CELLS TO IMPROVE T1D THERAPEUTIC STRATEGY | Regents of the University of Colorado | Mayumi Fujita | Cures | 01-March-2023 to 28-February-2026 | $750.000,00 |
A Novel Magnetorheological Insulin Pump | Georgia Southern University Research and Service Foundation, Inc | Sevki Cesmeci | Improving Lives | 01-June-2023 to 31-May-2026 | $199.516,50 |
Engineered Nanocapsules for Targeted Drug Delivery to the β-Cell | Colorado School of Mines | Nikki Farnsworth | Cures | 01-April-2023 to 31-March-2026 | $900.000,00 |